Sickle cell disease and implementation science: A partnership to accelerate advances

Allison A. King, Ana A. Baumann

Research output: Contribution to journalReview article

3 Scopus citations

Abstract

Sickle cell disease (SCD) results in end organ damage and a shortened lifespan. Both the pathophysiology of the disease and the social determinants of health affect patient outcomes. Randomized controlled trials have been completed among this population and resulted in medical advances; however, the gestation of these advances and the lack of penetrance into clinical practice have limited advancements in clinical improvements for many people with SCD. We discuss the role of implementation science in SCD and highlight the need for this science to shorten the length of time to implement evidence-based care for more people with SCD.

Original languageEnglish
Article numbere26649
JournalPediatric Blood and Cancer
Volume64
Issue number11
DOIs
StatePublished - Nov 2017

Keywords

  • implementation science
  • public health
  • sickle cell disease

Fingerprint Dive into the research topics of 'Sickle cell disease and implementation science: A partnership to accelerate advances'. Together they form a unique fingerprint.

  • Cite this